Anti-tumor effects and mechanism of 4′-bromo-resveratrol in a BRAFV600F/PTENNULL melanoma mouse model

被引：0
|
作者：
Chhabra, G. [1 ]
Singh, C. K. [1 ]
Ndiaye, M. A. [1 ]
Ahmad, N. [1 ]
机构：
[1] Univ Wisconsin, Dermatol, Madison, WI USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2020年 / 140卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
689
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [11] Anti-tumor effects of resveratrol on malignant melanoma is associated with promoter demethylation of RUNX3 gene
    Kang, Sisi
    Wang, Zhuo
    Li, Bin
    Gao, Xiujuan
    He, Wenjuan
    Cao, Sisi
    Cai, Yue
    Chen, Hui
    PHARMAZIE, 2019, 74 (03): : 163 - 167
  • [12] The Anti-Tumor Activity of a Neutralizing Nanobody Targeting Leptin Receptor in a Mouse Model of Melanoma
    McMurphy, Travis
    Xiao, Run
    Magee, Daniel
    Slater, Andrew
    Zabeau, Lennart
    Tavernier, Jan
    Cao, Lei
    PLOS ONE, 2014, 9 (02):
  • [13] Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol
    Ma, Zengshuan
    Molavi, Ommoleila
    Haddadi, Azita
    Lai, Raymond
    Gossage, Robert A.
    Lavasanifar, Afsaneh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 27 - 35
  • [14] Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol
    Zengshuan Ma
    Ommoleila Molavi
    Azita Haddadi
    Raymond Lai
    Robert A. Gossage
    Afsaneh Lavasanifar
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 27 - 35
  • [15] Exposure to ultraviolet light enhances anti-tumor immunity and response to immunotherapy in a mouse model of melanoma
    Damsky, W.
    Wang, J.
    Perry, C.
    Meeth, K.
    Kaech, S.
    Bosenberg, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S132 - S132
  • [16] The anti-tumor effects of an adenoviral vaccine expressing 4-1BB ligand in a murine melanoma model
    Ragonnaud, E.
    Andersson, A.
    Jensen, B. A. H.
    Thomsen, A. R.
    Holst, P. J.
    IMMUNOLOGY, 2012, 137 : 723 - 723
  • [17] Treatment with synthetic RIG-I agonist triphosphate RNA leads to local and systemic anti-tumor effects in a mouse melanoma tumor model
    Helms, Mike W.
    Parmantier, Eric
    Jahn-Hofmann, Kerstin
    Gnerlich, Felix
    Koenig, Lars
    Metz-Weidmann, Christiane
    Braun, Monika
    Dietert, Gabriele
    Grandien, Kaj
    Theilhaber, Joachim
    Cao, Hui
    Wagenaar, Tim
    Schnurr, Max
    Endres, Stefan
    Wiederschain, Dmitri
    Scheidler, Sabine
    Rothenfusser, Simon
    Brunner, Bodo
    CANCER RESEARCH, 2019, 79 (13)
  • [18] Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model
    Xian-ping Liu
    Sheng-tao Zhou
    Xing-yi Li
    Xian-cheng Chen
    Xia Zhao
    Zhi-yong Qian
    Li-na Zhou
    Zhi-yong Li
    Yu-mei Wang
    Qian Zhong
    Tao Yi
    Zheng-yu Li
    Xiang He
    Yu-quan Wei
    Journal of Experimental & Clinical Cancer Research, 29
  • [19] Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model
    Elzaouk, Lina
    Moelling, Karin
    Pavlovic, Jovan
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (11) : 865 - 874
  • [20] Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model
    Schad, Sara
    Hirschhorn-Cymerman, Daniel
    Budhu, Sadna
    Zhong, Hong
    Yang, Xia
    Merghoub, Taha
    Wolchok, Jedd D.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345